{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"mild-phosphoribosylpyrophosphate-synthetase-superactivity","columns":[{"gene":"","key":"population-b40dd7181fc0edfb86cf","label":"Mild phosphoribosylpyrophosphate synthetase superactivity","mondoId":"MONDO:0018463","onsetQualifier":null,"originColumnKey":"MONDO:0018463/ORPHA:411536","originalViews":[{"key":"MONDO:0018463/ORPHA:411536","label":"Mild phosphoribosylpyrophosphate synthetase superactivity","scopeLabel":"ORPHA:411536","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1fcac11f4c8b96df952068dffe3ffad8169c5d30c0f800641897c18d65cc25a3","24831ad53db329eccd50343ae572d5b2206c76f3bd1406b8abf13ceaa2023d54","2b91e656759c477030dc0fa4d7d6258b66affe87390eda627eab840b13d4ace3","48f0b000949363dae25f6b732d0bc45580625cd1c90f602f298dc3d19b016fe8","4eac09e76bc5ef0c539db655eec3244b36735c89cbae810e1cd30222773a0900","53bda33a350736b7ec724aabef554f1aed6f8c468c75c3ea4f56912fb3478409","68c097c369e1e8b18fae2410e0966afddc10ad9b0d94e03133f5c7f184f97a0b","8a75ddaf48e64a14cf8e4b99f66cc7e5f7f9bcaedf42fc73bbbab89c1d04b6de","8ead9840d91138a21115def5f3d4908a691bba23a82ab3568aa805d62920b6d3","96183a6d603ecb68e2aebe9de08aaac772ce574fd37749db501d435bf8409b20","bdc1f9c1206df5c2f7b55b21dae2c3f02fd1caf88e5ac350f02acc2d73fdb6ec","cb2e9c513af41bced155bd512437f04a60641c023497722f70e2f0af6f049d0e","ccd4edf3a165dcba788bd292efa699ff03e0c97ea2ba627b0074cba71d3a70eb","d60ab934fcb3432a83ec9b541319c8c8a7e4f319d278b831ad93d45731ce4487","f10f26d72d9fd7adc022b8a9b87e1ec7acf18c2600ede68d63dea76a20ae14df"],"recordQualifiers":{},"scopeLabel":"ORPHA:411536","sourceIds":["ORPHA:411536"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b40dd7181fc0edfb86cf"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001999","HP:0000478","HP:0000707","HP:0001919","HP:0001369","HP:0020074","HP:0002149"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"orphanet":15}},"features":[{"hpoId":"HP:0001999","label":"Abnormal facial shape","primary":true},{"hpoId":"HP:0000478","label":"Abnormality of the eye","primary":true},{"hpoId":"HP:0000707","label":"Abnormality of the nervous system","primary":true},{"hpoId":"HP:0001919","label":"Acute kidney injury","primary":true},{"hpoId":"HP:0001369","label":"Arthritis","primary":true},{"hpoId":"HP:0020074","label":"Crystalluria","primary":true},{"hpoId":"HP:0002149","label":"Hyperuricemia","primary":true},{"hpoId":"HP:0003149","label":"Hyperuricosuria","primary":false},{"hpoId":"HP:0003240","label":"Increased phosphoribosylpyrophosphate synthetase level","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0012626","label":"Stage 4 chronic kidney disease","primary":false},{"hpoId":"HP:0000791","label":"Uric acid nephrolithiasis","primary":false}],"ledeHtml":"Mild phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the mild and late-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, leading to urolithiasis and gout. This form is not associated with any neuropathy or central nervous system (CNS) disorders.","mondoId":"MONDO:0018463","node":{"canonicalSlug":"mild-phosphoribosylpyrophosphate-synthetase-superactivity","comparisons":[{"documentSha256":"f9d6d13752964acdd86bf87920ef80307f8fe296bea726989345e46023dad362","key":"legacy-phosphoribosylpyrophosphate-synthetase-superactivity","kind":"legacy","label":"phosphoribosylpyrophosphate synthetase superactivity","memberIds":["MONDO:0010395","MONDO:0018463","MONDO:0018464"],"mondoId":"MONDO:0010395","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/phosphoribosylpyrophosphate-synthetase-superactivity.f9d6d13752964acdd86bf87920ef80307f8fe296bea726989345e46023dad362.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"mild phosphoribosylpyrophosphate synthetase superactivity","paragraphs":["Mild phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the mild and late-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, leading to urolithiasis and gout. This form is not associated with any neuropathy or central nervous system (CNS) disorders."],"scope":"exact","source":"MONDO","upstream":"Orphanet:411536","url":"https://monarchinitiative.org/MONDO:0018463"},"ownColumnKeys":["population-b40dd7181fc0edfb86cf"],"publication":"published","relationships":[{"kind":"parent","label":"phosphoribosylpyrophosphate synthetase superactivity","mondoId":"MONDO:0010395","slug":"phosphoribosylpyrophosphate-synthetase-superactivity"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17681"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"1fcac11f4c8b96df952068dffe3ffad8169c5d30c0f800641897c18d65cc25a3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24831ad53db329eccd50343ae572d5b2206c76f3bd1406b8abf13ceaa2023d54","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001919","is_excluded":false,"label":"Acute kidney injury","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"2b91e656759c477030dc0fa4d7d6258b66affe87390eda627eab840b13d4ace3","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000478","is_excluded":true,"label":"Abnormality of the eye","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"48f0b000949363dae25f6b732d0bc45580625cd1c90f602f298dc3d19b016fe8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003240","is_excluded":false,"label":"Increased phosphoribosylpyrophosphate synthetase level","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4eac09e76bc5ef0c539db655eec3244b36735c89cbae810e1cd30222773a0900","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003149","is_excluded":false,"label":"Hyperuricosuria","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"53bda33a350736b7ec724aabef554f1aed6f8c468c75c3ea4f56912fb3478409","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"68c097c369e1e8b18fae2410e0966afddc10ad9b0d94e03133f5c7f184f97a0b","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000407","is_excluded":true,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8a75ddaf48e64a14cf8e4b99f66cc7e5f7f9bcaedf42fc73bbbab89c1d04b6de","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009830","is_excluded":true,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8ead9840d91138a21115def5f3d4908a691bba23a82ab3568aa805d62920b6d3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":true,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96183a6d603ecb68e2aebe9de08aaac772ce574fd37749db501d435bf8409b20","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000791","is_excluded":false,"label":"Uric acid nephrolithiasis","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bdc1f9c1206df5c2f7b55b21dae2c3f02fd1caf88e5ac350f02acc2d73fdb6ec","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002149","is_excluded":false,"label":"Hyperuricemia","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb2e9c513af41bced155bd512437f04a60641c023497722f70e2f0af6f049d0e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012626","is_excluded":false,"label":"Stage 4 chronic kidney disease","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ccd4edf3a165dcba788bd292efa699ff03e0c97ea2ba627b0074cba71d3a70eb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0020074","is_excluded":false,"label":"Crystalluria","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d60ab934fcb3432a83ec9b541319c8c8a7e4f319d278b831ad93d45731ce4487","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001999","is_excluded":true,"label":"Abnormal facial shape","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f10f26d72d9fd7adc022b8a9b87e1ec7acf18c2600ede68d63dea76a20ae14df","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411536","disease_name":"Mild phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000707","is_excluded":false,"label":"Abnormality of the nervous system","onset_id":null,"reference":"ORPHA:411536","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018463\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:411536</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Mild phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the mild and late-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, leading to urolithiasis and gout. This form is not associated with any neuropathy or central nervous system (CNS) disorders.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018463\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"mild-phosphoribosylpyrophosphate-synthetase-superactivity","sourceDocuments":[{"name":"MONDO: mild phosphoribosylpyrophosphate synthetase superactivity","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018463"}],"sourceNote":"","synonyms":["mild PRPP synthetase superactivity","mild PRPS1 superactivity"],"takeawayHtml":"","title":"mild phosphoribosylpyrophosphate synthetase superactivity"},"schemaVersion":1}
